ビフィズス菌の世界市場

ビフィズス菌の世界市場は2030年までに11億米ドルに達する見込み

2024年に7億7,580万米ドルと推定されるビフィズス菌の世界市場は、2024年から2030年にかけてCAGR 6.7%で成長し、2030年には11億米ドルに達すると予測されます。ビフィズス菌ロンガムは、本レポートで分析したセグメントの1つであり、分析期間終了時にはCAGR 8.3％を記録し、2億4,490万米ドルに達すると予測されています。ビフィズス菌Breveセグメントの成長率は、分析期間中CAGR 7.0％と推定されます。

米国市場は2億1,140万米ドルと推定、中国はCAGR 10.7％で成長予測

米国のビフィズス菌市場は、2024年に2億1,140万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを10.7%として、2030年までに2億4,020万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.3％と6.6％と予測されています。欧州では、ドイツがCAGR 4.4%で成長すると予測されています。

世界のビフィズス菌市場- 主要動向と促進要因のまとめ

ビフィズス菌が健康・ウェルネス産業で人気を集める理由とは？

ビフィズス菌は、人間の腸内で自然に発見される有益なプロバイオティクス属であり、消化器系の健康、免疫力、全体的な幸福に多大な影響を与えることから、健康・ウェルネス産業で注目の的となっています。健康維持における腸内細菌叢の重要な役割が科学的に調査されるにつれ、プロバイオティクスサプリメント、機能性食品、個別栄養ソリューションに対する消費者の関心が高まっています。ビフィズス菌は、腸内細菌叢のバランスを整え、消化を改善し、栄養吸収を高めることによって腸の健康をサポートする能力で広く認知されています。また、免疫システムを強化し、炎症を抑え、過敏性腸症候群（IBS）や乳糖不耐症などの胃腸障害を緩和する上で極めて重要な役割を果たしています。

肥満、糖尿病、自己免疫疾患など、ライフスタイルに関連した健康問題の有病率の上昇が、ビフィズス菌のようなプロバイオティクスの需要をさらに押し上げています。ヨーグルト、ケフィア、コンブチャ、栄養補助食品など、プロバイオティクスを強化した機能性食品や飲食品は、消費者が腸内マイクロバイオームを強化する自然な方法を求めているため、急激な成長を遂げています。さらに、マイクロバイオーム研究の進歩により、プロバイオティクスの潜在的用途は消化器系の健康だけでなく、メンタルヘルス、肌の健康、代謝調節などにも関連する新たな研究が進んでいます。個別化栄養学が普及するにつれ、個々のマイクロバイオーム組成に合わせたプロバイオティクス製剤は市場に革命を起こし、ビフィズス菌を現代的な健康ソリューションの要として位置づけることになるでしょう。

技術の進歩はビフィズス菌ベースの製品をどのように強化していますか？

プロバイオティクスの製剤、送達システム、マイクロバイオーム調査における技術革新は、ビフィズス菌ベースの製品の有効性と安定性を著しく向上させました。この分野における最も重要な進歩の一つがマイクロカプセル化技術で、熱、湿気、胃酸からプロバイオティクスを保護することにより、プロバイオティクスの生存率を高めています。これにより、生きた細菌がより高い割合で腸に届き、有益な効果を発揮することができます。さらに、凍結乾燥（凍結乾燥）技術により、プロバイオティクスの保存性が向上し、栄養補助食品、機能性食品、医薬品への応用が可能になりました。

プロバイオティクス科学におけるもう一つの画期的な進歩は、特定の健康状態に対応する特定菌株製剤の開発です。研究者たちは、ビフィズス菌longum、ビフィズス菌breve、ビフィズス菌bifidumなど、それぞれ異なる健康効果をもたらすビフィズス菌の菌株を特定し、分離しています。例えば、ある菌株は過敏性腸症候群（IBS）の症状を軽減し、他の菌株は認知機能を改善し、不安を軽減することが示されています。マイクロバイオーム解析におけるDNAシークエンシングと人工知能（AI）の統合は、プロバイオティクス製剤の精度をさらに高め、個別化プロバイオティクス療法への道を開いています。さらに、ビフィズス菌とイヌリンやフラクトオリゴ糖（FOS）などのプレバイオティクスを組み合わせた共生型製剤の進歩により、腸内の有益な細菌の増殖と活性が促進され、プロバイオティクスの効能が向上しています。

どのような市場動向がビフィズス菌ベースの製品の成長を促進しているか？

世界のビフィズス菌市場は、自然な健康ソリューションや予防ヘルスケアへの消費者シフトの高まりに後押しされ、急速に拡大しています。市場を形成する最も影響力のある動向の一つは、プロバイオティクスを配合した機能性食品や飲食品に対する需要の増加です。ヨーグルトや発酵乳飲料など、乳製品をベースとするプロバイオティクス製品は長い間、市場で優位を占めてきたが、菜食主義者や乳糖不耐症の消費者の増加により、植物ベースや非乳製品の代替品が人気を集めています。さらに、プロバイオティクス強化スナック、プロテイン・バー、さらにはコーヒーまでもが、消費者が毎日の食生活に有益なバクテリアを取り入れる革新的な方法として台頭してきています。

市場に影響を与えるもう1つの主な動向は、腸の健康と精神的幸福との関連性を強調する腸脳軸に対する認識の高まりです。特定の菌株が神経伝達物質の産生に影響を与え、ストレスを軽減し、気分を改善することが研究で示されています。その結果、プロバイオティクスは、認知機能を高めるサプリメントやストレス緩和製剤など、メンタル・ウェルネス製品への配合が増加しています。さらに、小児用プロバイオティクスへの関心の高まりから、幼少期の免疫系の発達や消化器系の健康をサポートするビフィズス菌を配合した乳児用調製粉乳や子供用サプリメントが開発されています。また、オンライン小売チャネルと消費者直販の拡大も、プロバイオティクスの利点に関する入手しやすさと消費者教育の向上に極めて重要な役割を果たしています。

ビフィズス菌市場の将来を形作る主な成長促進要因は何か？

ビフィズス菌市場の成長は、プロバイオティクスの科学的検証の増加、腸内健康ソリューションに対する消費者の需要の高まり、バイオテクノロジーの進歩など、いくつかの重要な要因によって牽引されています。主な促進要因の一つは、ビフィズス菌の健康上の利点を裏付ける臨床研究の拡大であり、ヘルスケア専門家や消費者の間でより大きな受け入れにつながっています。消化器系疾患の管理、免疫力の向上、さらには精神的健康への影響など、プロバイオティクスの役割を実証する研究が増えるにつれ、高品質のプロバイオティクス製品に対する需要は高まり続けています。さらに、欧州食品安全機関（EFSA）や米国食品医薬品局（FDA）などの機関による規制上の承認や健康強調表示が、プロバイオティクスの有効性と安全性に対する消費者の信頼を高めています。

市場を形成するもう一つの主要促進要因は、微生物に焦点を当てた新興企業や研究イニシアティブへの投資の増加です。バイオテクノロジー企業は、バイオアベイラビリティ、安定性、標的治療用途を強化した次世代プロバイオティクス製剤を開発しています。ビフィズス菌に基づく胃腸障害や代謝疾患治療薬の開発など、プロバイオティクスの医薬品分野への応用拡大により、新たな市場機会が開かれることが期待されます。さらに、持続可能で自然な健康ソリューションへの関心の高まりは、プロバイオティクス生産における技術革新の原動力となっており、各社はプロバイオティクス菌株を強化するための発酵ベースや生物工学的手法を模索しています。腸の健康に対する消費者の意識が高まり続け、科学の進歩が新たなプロバイオティクスの機能性を解き放つにつれて、ビフィズス菌市場は持続的な拡大の態勢を整え、個別化された健康とウェルネス・ソリューションの未来を形作る。

セグメント

製品タイプ（ビフィズス菌Longum、ビフィズス菌Breve、ビフィズス菌Animalis、ビフィズス菌Infantis、ビフィズス菌Lactis、その他の製品タイプ）、用途（栄養補助食品用途、動物飼料用途、機能性食品および飲料用途、医薬品用途、その他の用途）

調査対象企業の例

• BioGaia
• BioGrowing Co., Ltd
• Chr. Hansen Holding A/S
• Danone S.A
• DSM-Firmenich AG
• DuPont de Nemours, Inc.
• Garden of Life
• General Mills, Inc.
• Kerry Group Plc
• Lallemand, Inc.
• Morinaga Milk Industry Co., Ltd.
• Nestle S.A.
• Probi AB
• Valio Oy
• Yakult Honsha Co., Ltd.

AIインテグレイションズ

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Bifidobacterium Market to Reach US$1.1 Billion by 2030

The global market for Bifidobacterium estimated at US$775.8 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Bifidobacterium Longum, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$244.9 Million by the end of the analysis period. Growth in the Bifidobacterium Breve segment is estimated at 7.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$211.4 Million While China is Forecast to Grow at 10.7% CAGR

The Bifidobacterium market in the U.S. is estimated at US$211.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$240.2 Million by the year 2030 trailing a CAGR of 10.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Bifidobacterium Market - Key Trends & Drivers Summarized

Why Is Bifidobacterium Gaining Popularity in the Health and Wellness Industry?

Bifidobacterium, a genus of beneficial probiotics naturally found in the human gut, has become a focal point in the health and wellness industry due to its profound impact on digestive health, immunity, and overall well-being. As scientific research continues to highlight the crucial role of gut microbiota in maintaining health, consumer interest in probiotic supplements, functional foods, and personalized nutrition solutions has surged. Bifidobacterium is widely recognized for its ability to support gut health by balancing intestinal flora, improving digestion, and enhancing nutrient absorption. It also plays a pivotal role in strengthening the immune system, reducing inflammation, and mitigating gastrointestinal disorders such as irritable bowel syndrome (IBS) and lactose intolerance.

The rising prevalence of lifestyle-related health issues, including obesity, diabetes, and autoimmune conditions, has further driven demand for probiotics like Bifidobacterium. Functional foods and beverages enriched with probiotics, including yogurt, kefir, kombucha, and dietary supplements, have witnessed exponential growth as consumers seek natural ways to enhance their gut microbiome. Additionally, advancements in microbiome research have expanded the potential applications of Bifidobacterium beyond digestive health, with emerging studies linking its benefits to mental health, skin health, and metabolic regulation. As personalized nutrition gains traction, probiotic formulations tailored to individual microbiome compositions are set to revolutionize the market, positioning Bifidobacterium as a cornerstone of modern health solutions.

How Are Technological Advancements Enhancing Bifidobacterium-Based Products?

Technological innovations in probiotic formulation, delivery systems, and microbiome research have significantly improved the efficacy and stability of Bifidobacterium-based products. One of the most important advancements in this field is microencapsulation technology, which enhances the survivability of probiotics by protecting them from heat, moisture, and stomach acid. This ensures that a higher percentage of live bacteria reach the intestines, where they can exert their beneficial effects. Additionally, freeze-drying (lyophilization) techniques have improved the shelf life of Bifidobacterium probiotics, making them more viable for use in dietary supplements, functional foods, and pharmaceutical applications.

Another major breakthrough in probiotic science is the development of targeted strain-specific formulations that cater to specific health conditions. Researchers are identifying and isolating different strains of Bifidobacterium, such as Bifidobacterium longum, Bifidobacterium breve, and Bifidobacterium bifidum, each of which offers distinct health benefits. For example, certain strains have been shown to reduce symptoms of irritable bowel syndrome (IBS), while others improve cognitive function and reduce anxiety. The integration of DNA sequencing and artificial intelligence (AI) in microbiome analysis is further enhancing the precision of probiotic formulations, paving the way for personalized probiotic therapies. Moreover, advancements in symbiotic formulations-combining Bifidobacterium with prebiotics such as inulin or fructooligosaccharides (FOS)-are improving probiotic efficacy by fostering the growth and activity of beneficial bacteria in the gut.

Which Market Trends Are Driving the Growth of Bifidobacterium-Based Products?

The global Bifidobacterium market is expanding rapidly, fueled by the growing consumer shift toward natural health solutions and preventive healthcare. One of the most influential trends shaping the market is the increasing demand for functional foods and beverages infused with probiotics. Dairy-based probiotic products, including yogurt and fermented milk drinks, have long been dominant in the market, but plant-based and non-dairy alternatives are gaining traction due to the rise of vegan and lactose-intolerant consumers. Additionally, probiotic-fortified snacks, protein bars, and even coffee are emerging as innovative ways for consumers to incorporate beneficial bacteria into their daily diets.

Another key trend influencing the market is the rising awareness of the gut-brain axis, which highlights the connection between gut health and mental well-being. Studies have shown that certain strains of Bifidobacterium can influence neurotransmitter production, reduce stress, and improve mood. As a result, probiotics are being increasingly incorporated into mental wellness products, including cognitive-enhancing supplements and stress-relief formulations. Furthermore, the growing interest in pediatric probiotics has led to the development of infant formulas and children's supplements containing Bifidobacterium to support immune system development and digestive health in early life. The expansion of online retail channels and direct-to-consumer sales is also playing a pivotal role in increasing accessibility and consumer education about the benefits of probiotics.

What Are the Key Growth Drivers Shaping the Future of the Bifidobacterium Market?

The growth in the Bifidobacterium market is driven by several critical factors, including increasing scientific validation of probiotics, rising consumer demand for gut health solutions, and advancements in biotechnology. One of the primary drivers is the expanding body of clinical research supporting the health benefits of Bifidobacterium, leading to greater acceptance among healthcare professionals and consumers. As more studies demonstrate its role in managing digestive disorders, boosting immunity, and even influencing mental health, the demand for high-quality probiotic products continues to rise. Additionally, regulatory approvals and health claims by organizations such as the European Food Safety Authority (EFSA) and the U.S. Food and Drug Administration (FDA) are bolstering consumer confidence in probiotic efficacy and safety.

Another key driver shaping the market is the increasing investment in microbiome-focused startups and research initiatives. Biotech companies are developing next-generation probiotic formulations with enhanced bioavailability, stability, and targeted therapeutic applications. The expansion of probiotic applications into the pharmaceutical sector, including the development of Bifidobacterium-based drugs for gastrointestinal disorders and metabolic conditions, is expected to open new market opportunities. Additionally, the growing interest in sustainable and natural health solutions is driving innovation in probiotic production, with companies exploring fermentation-based and bioengineered methods to enhance probiotic strains. As consumer awareness of gut health continues to grow and scientific advancements unlock new probiotic functionalities, the Bifidobacterium market is poised for sustained expansion, shaping the future of personalized health and wellness solutions.

SCOPE OF STUDY:

The report analyzes the Bifidobacterium market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis, Other Product Types); Application (Dietary Supplements Application, Animal Feed Application, Functional Food and Beverages Application, Pharmaceuticals Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• BioGaia
• BioGrowing Co., Ltd
• Chr. Hansen Holding A/S
• Danone S.A
• DSM-Firmenich AG
• DuPont de Nemours, Inc.
• Garden of Life
• General Mills, Inc.
• Kerry Group Plc
• Lallemand, Inc.
• Morinaga Milk Industry Co., Ltd.
• Nestle S.A.
• Probi AB
• Valio Oy
• Yakult Honsha Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Bifidobacterium - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Growing Focus on Gut Health and Microbiome Wellness Throws the Spotlight on Bifidobacterium-Based Products
  • Rising Demand for Probiotic-Rich Functional Foods Drives Market Growth for Bifidobacterium Strains
  • Increasing Consumer Awareness of Digestive and Immune Health Expands Addressable Market Opportunity
  • Scientific Validation of Bifidobacterium's Role in Microbiota Balance Strengthens the Business Case for Probiotic Supplementation
  • Surge in Prebiotic and Synbiotic Product Development Spurs Innovation in Bifidobacterium Combinations
  • Growth of Personalized Nutrition and Microbiome Testing Accelerates Demand for Targeted Bifidobacterium Strains
  • Rising Incidence of Antibiotic-Associated Gut Dysbiosis Propels Use of Bifidobacterium in Post-Antibiotic Therapy
  • Infant and Pediatric Nutrition Segment Drives High Demand for Bifidobacterium-Infused Formulas and Supplements
  • Clean Label and Natural Health Product Trends Fuel Interest in Fermented Foods Containing Bifidobacterium Cultures
  • Expanding Use of Bifidobacterium in Women's Health and Metabolic Wellness Products Creates New Market Opportunities
  • Growth in Aging Population and Cognitive Wellness Awareness Spurs Bifidobacterium Application in Healthy Aging Products
  • Advancements in Encapsulation and Delivery Technologies Enhance Viability and Shelf-Stability of Bifidobacterium Products
  • Rising Interest in Mental Wellness and Gut-Brain Axis Fuels Demand for Psychobiotic Bifidobacterium Strains
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Bifidobacterium Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Bifidobacterium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Bifidobacterium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Bifidobacterium by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Bifidobacterium Longum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Bifidobacterium Longum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Bifidobacterium Longum by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Bifidobacterium Breve by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Bifidobacterium Breve by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Bifidobacterium Breve by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Bifidobacterium Animalis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Bifidobacterium Animalis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Bifidobacterium Animalis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Bifidobacterium Infantis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Bifidobacterium Infantis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Bifidobacterium Infantis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Bifidobacterium Lactis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Bifidobacterium Lactis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Bifidobacterium Lactis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Pharmaceuticals Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Pharmaceuticals Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Pharmaceuticals Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Dietary Supplements Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Dietary Supplements Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Dietary Supplements Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Animal Feed Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Animal Feed Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Animal Feed Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Functional Food & Beverages Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Functional Food & Beverages Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Functional Food & Beverages Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• JAPAN
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• CHINA
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 56: China Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: China 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• EUROPE
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 62: Europe Recent Past, Current & Future Analysis for Bifidobacterium by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 63: Europe Historic Review for Bifidobacterium by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Europe 15-Year Perspective for Bifidobacterium by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Europe 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• FRANCE
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 71: France Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: France Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: France 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 74: France Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: France Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: France 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• GERMANY
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 77: Germany Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Germany Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Germany 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 80: Germany Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Germany Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Germany 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 83: Italy Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Italy Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Italy 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 86: Italy Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Italy Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Italy 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 89: UK Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: UK Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: UK 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 92: UK Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: UK Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: UK 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 95: Spain Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Spain Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Spain 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 98: Spain Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Spain Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Spain 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 101: Russia Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Russia Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Russia 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 104: Russia Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Russia Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Russia 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Rest of Europe Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Rest of Europe 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Rest of Europe Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: Rest of Europe 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Bifidobacterium by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 114: Asia-Pacific Historic Review for Bifidobacterium by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Asia-Pacific 15-Year Perspective for Bifidobacterium by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Asia-Pacific Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Asia-Pacific 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Asia-Pacific Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Asia-Pacific 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 122: Australia Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Australia Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Australia 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 125: Australia Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Australia Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Australia 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• INDIA
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 128: India Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: India Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: India 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 131: India Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: India Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: India 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 134: South Korea Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: South Korea Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: South Korea 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 137: South Korea Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: South Korea Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: South Korea 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Asia-Pacific Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Asia-Pacific 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Asia-Pacific Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Asia-Pacific 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 146: Latin America Recent Past, Current & Future Analysis for Bifidobacterium by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 147: Latin America Historic Review for Bifidobacterium by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Latin America 15-Year Perspective for Bifidobacterium by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 149: Latin America Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Latin America Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Latin America 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 152: Latin America Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Latin America Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Latin America 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 155: Argentina Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Argentina Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Argentina 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 158: Argentina Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Argentina Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Argentina 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 161: Brazil Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Brazil Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Brazil 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 164: Brazil Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Brazil Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Brazil 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 167: Mexico Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Mexico Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Mexico 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 170: Mexico Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Mexico Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Mexico 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Rest of Latin America Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Rest of Latin America 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Latin America Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Latin America 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 179: Middle East Recent Past, Current & Future Analysis for Bifidobacterium by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 180: Middle East Historic Review for Bifidobacterium by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Middle East 15-Year Perspective for Bifidobacterium by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 182: Middle East Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Middle East Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Middle East 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 185: Middle East Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Middle East Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Middle East 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 188: Iran Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Iran Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Iran 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 191: Iran Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Iran Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Iran 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 194: Israel Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Israel Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Israel 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 197: Israel Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Israel Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Israel 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Saudi Arabia Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Saudi Arabia 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Saudi Arabia Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Saudi Arabia 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 206: UAE Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: UAE Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: UAE 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 209: UAE Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: UAE Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: UAE 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Rest of Middle East Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Rest of Middle East 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Rest of Middle East Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Rest of Middle East 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030
• AFRICA
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 218: Africa Recent Past, Current & Future Analysis for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Africa Historic Review for Bifidobacterium by Product Type - Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Africa 15-Year Perspective for Bifidobacterium by Product Type - Percentage Breakdown of Value Sales for Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 221: Africa Recent Past, Current & Future Analysis for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Africa Historic Review for Bifidobacterium by Application - Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Africa 15-Year Perspective for Bifidobacterium by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Other Applications, Dietary Supplements Application, Animal Feed Application and Functional Food & Beverages Application for the Years 2015, 2025 & 2030

IV. COMPETITION